OVB — Ovoca Bio Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Ovoca Bio, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 10.7 | 6.59 | 3.7 | 3.34 | 2.51 |
| Net Total Receivables | 0.043 | 0.334 | 1.23 | 0.121 | 0.058 |
| Total Inventory | |||||
| Total Current Assets | 11.1 | 7.02 | 4.98 | 3.46 | 2.56 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.007 | 0.018 | 0 | 0 | 0 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 19 | 14.8 | 9.4 | 3.47 | 2.65 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.449 | 1.34 | 1.56 | 0.528 | 0.368 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.486 | 1.34 | 1.77 | 0.967 | 0.594 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 18.6 | 13.4 | 7.63 | 2.5 | 2.06 |
| Total Liabilities & Shareholders' Equity | 19 | 14.8 | 9.4 | 3.47 | 2.65 |
| Total Common Shares Outstanding |